retatrutide type 2 diabetes phase 2 trial results 2024 produces up to 30.3% weight loss in 3 New clinical trial results show

Koundouros N, Poulogiannis G

Proton pump inhibitors (PPIs): Medications like omeprazole and pantoprazole further reduce stomach acid, compounding the B12 absorption problem

doi: 10.4049/jimmunol.179.5.2979 40 LammertF.GurusamyK.KoC

Colchicine and IL-1 inhibitor Canakinumab showed a reduction in major cardiovascular events in patients with previous myocardial infarction, but with no benefits on death by any cause [15,16,17]

Because the health benefits of obesity treatment generally outweigh these temporary challenges, both proactive prevention strategies and effective support are crucial during periods of therapy adjustment

Combining the validation results with the bioinformatic analysis, we therefore chose the most upregulated protein (SCD1) as the main target protein in this study